Endocrinology/Metabolics Market Research Reports & Industry Analysis
Endocrinologists are specially trained doctors in treating hormone imbalances and problems. Most endocrine disorders are chronic and need continuous treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid and hyperparathyroid disorders, and osteoporosis. Some less common but serious endocrine disorders include, but are not limited to: Addison’s disease, Cushing’s syndrome, pheochromocytoma, and disorders of sexual development.
In the United States, the most common endocrine disease is diabetes mellitus. Diabetes mellitus is a group of diseases categorized by a deficiency in insulin production or the ability of the body to use it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes has made endocrinology/metabolics one of the most in-demand and important medical sects.
Endocrinology/Metabolics Industry Research & Market Reports
-
2023 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... Size & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through ... Read More
-
Metabolic Collaboration and Licensing Deals 2016-2023
... the report provides details of metabolic deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal ... Read More
-
Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
... and Key Companies, 2023 Update provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. ... Read More
-
Human Growth Hormone Drugs
... to reach a revised size of US$4.8 Billion by 2030, growing at a CAGR of 4% over the period 2022-2030. Subcutaneous, one of the segments analyzed in the report, is projected to record 4.5% CAGR ... Read More
-
2023 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Global Recession Risk Impact
... & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, ... Read More
-
Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region - Global Forecast to 2028
... global clinical chemistry analyzers market size is projected to reach USD 16.5 billion by 2028 from USD 13.0 billion in 2023, at a CAGR of 4.9% during the forecast period. The clinical chemistry analyzers market ... Read More
-
Metabolic Disorder Therapeutics
... year 2022, is projected to reach a revised size of US$136.6 Billion by 2030, growing at aCAGR of 8.1% over the period 2022-2030. Diabetes, one of the segments analyzed in the report, is projected to ... Read More
-
Global Metabolic Partnering 2016-2023: Deal trends, players and financials
... in metabolic partnering deals Financial deal terms for headline, upfront and royalty by stage of development Metabolic partnering agreement structure Metabolic partnering contract documents Top metabolic deals by value Most active metabolic dealmakers Most of ... Read More
-
Metabolic Testing Solutions
... year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will ... Read More
-
Rare Endocrine Disease Treatment
... Billion in the year 2022, is projected to reach a revised size of US$12.9 Billion by 2030, growing at aCAGR of 3.5% over the period 2022-2030. Acromegaly, one of the segments analyzed in the report, ... Read More
-
Testosterone Replacement Therapy (TRT)
... Billion in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at aCAGR of 4.1% over the period 2022-2030. Topicals, one of the segments analyzed in the report, ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... capita consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal ... Read More
-
Hormone Replacement Therapy (HRT)
... this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation ... Read More
-
Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global laboratory developed tests market size is expected to reach USD 16.72 billion by 2030, expanding at a CAGR of 6.58% from 2023 to 2030, according to a new report by ... Read More
-
Global Addison's Disease Therapeutics Market 2023-2027
... Our report on Addison's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Endocrinology Drugs Market 2023-2027
... report on the endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) [PL2]
... Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End ... Read More
-
Global Cord Blood Banking Market By Service (Sample Preservation & Storage, Sample Analysis, Sample Processing, Sample Collection & Transportation), By Component (Cord Blood v/s Cord Tissue), By Application (Cancer Disease, Diabetes, Blood Disease, Immune Disorders, Metabolic Disorders, Others), By Sector (Public Cord Blood Banks v/s Private cord Blood Banks), By Company, and By Region, Competition Forecast and Opportunities, 2027
... Disorders, Metabolic Disorders, Others), By Sector (Public Cord Blood Banks v/s Private cord Blood Banks), By Company, and By Region, Competition Forecast and Opportunities, 2027 The global cord blood banking market is anticipated to observe ... Read More
-
2022 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders (E00-E89) Global Market Size & Growth Report with Updated Forecasts
... Figures are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell endocrine, nutritional and metabolic diseases, and immunity disorders (e00-e89) combined with country ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO ... Read More
-
Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Small molecule drugs have represented some of the crucial blockbusters in ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... terms of per capita consumption, the market was $10.7 and in terms of global GDP, the market was 0.09%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.6% preceded and ... Read More
-
2022 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders (E00-E89) Global Market Size & Growth Report with COVID-19 Impact
... & Growth Report covers market size, revenue, growth, and share across 4 global regions, 22 subregions, and 216 countries. Figures are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes ... Read More
-
India Thyroid Function Test Market, By Test Type (TSH, T3, T4, FT3, FT4, Others), By End User (Clinics, Research Organizations, Diagnostic Laboratories, Hospitals) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism and hyperthyroidism. Thyroid can be caused by iodine deficiency and autoimmune disease. Iodine deficiency is a major ... Read More
-
The 2023-2028 World Outlook for Hormone Replacement Therapies
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
Research Assistance
